MedAlliance is a developer of medical technology headquartered in Nyon, Switzerland. The company develops sirolimus micro-reservoir drug-coated balloon to treat patients suffering from peripheral artery disease (PAD), coronary artery disease (CAD), arteriovenous fistulas (AVF) and grafts (AVG) for end-stage renal disease.